Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XOSPATA safely and effectively. See full prescribing information for XOSPATA. XOSPATA® (gilteritinib) tablets, for oral useInitial U.S. Approval: 2018
Medication labelWhy this: Advisory · dailymed-prescription
XOSPATA is indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FMS-like tyrosine kinase 3 (FLT3) mutation as detected by an FDA-approved test.
- generic_name
- gilteritinib
- product_names
- gilteritinib
- ndc
- 0469-1425, 0469-1425-90, 0469-1425-21
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en